Malignant Biliary Tract Neoplasm — Trials

Malignant Biliary Tract Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,282 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 367
Recruiting: 209
Ph III recruiting: 19
Growth YoY: +15.9%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (152)

clinicaltrialsPublishedShowing 601–601 of 601 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00041808	Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver	completed	Phase 1 / Phase 2	20	FeRxINDUSTRY	2	Jun 24, 2005	clinicaltrials